Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04078347
Other study ID # TJ-IRB20190424
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 1, 2019
Est. completion date October 31, 2020

Study information

Verified date November 2020
Source Huazhong University of Science and Technology
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this prospective observational study was to evaluate the changes of skin temperature after the paravertebral block measured by infrared thermography.


Description:

Methods: Patients scheduled for elective surgery with paravertebral block will receive infrared thermography measures 5 min before the block and continous to 20 min after the block. The sensitivity, specificity of infrared thermography as diagnostic methods will be determined by receiver operator characteristic analysis.


Recruitment information / eligibility

Status Completed
Enrollment 61
Est. completion date October 31, 2020
Est. primary completion date August 30, 2020
Accepts healthy volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - With informed consent - American Society of Anesthesiologists physical status ?-? - Undergo elective surgery with planned paravertebral block Exclusion Criteria: - Refusal to participate in the study - pre-existing infection at the block site - younger than 18-yr-old - BMI>35 - significant thoracic kyphoscoliosis - Those who had taken vasodilatory drugs before surgery - history of previous thoracic or breast surgery - Preoperative analgesic medications - Any contraindications to peripheral nerve block such as coagulation abnormalities, allergy to local anaesthetics, peripheral neuropathy.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Paravertebral block at T4 and T5 level
Paravertebral block is performed at T4 and T5 level under realtime ultrasound guidenance with 10ml of 0.5% ropivacaine for each block, respectively.

Locations

Country Name City State
China Tongji Hospital Wuhan Hubei

Sponsors (1)

Lead Sponsor Collaborator
Huazhong University of Science and Technology

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes of skin temperature Changes of skin temperature determined by infrared thermography From baseline up to 20 minutes after block
Secondary Noinvasive blood pressure Vital signs From baseline up to 20 minutes after block
Secondary Heart rate Vital signs From baseline up to 20 minutes after block
Secondary SPO2 vital signs From baseline up to 20 minutes after block
Secondary Sensory block level Sensory block level determined by pinprick. From baseline up to 20 minutes after block
See also
  Status Clinical Trial Phase
Recruiting NCT05896150 - Intercostal Cryoanalgesia for Acute Pain After VATS Lung Resection N/A
Not yet recruiting NCT06082206 - Pectoral Nerve Block Versus Paravertebral Block In The Incidence of Chronic Pain After Mastectomy: N/A
Recruiting NCT06426706 - TPVB or SPSIPB in Pain Management After VATS N/A
Completed NCT04304274 - Programmed Intermittent Bolus Infusion of Thoracic Paravertebral Block for Hepatectomy N/A
Completed NCT03990922 - CTPVB for Hepatectomy N/A
Completed NCT05713643 - ESPB vs PVB vs QLB After Pelvi-ureteric Surgeries N/A
Recruiting NCT06231355 - Liposomal vs. Conventional Bupivacaine for Pain Control Phase 4
Enrolling by invitation NCT05822076 - Influence of Thoracic Paravertebral Block on Cardiac Repolarization
Completed NCT06011746 - Adding Ketamine to Levobupivacaine in Paravertebral Block in Thoracotomy Phase 4
Not yet recruiting NCT05816538 - The Immune Response of Breast Cancer Patients Treated With Levobupivacaine Using Paravertebral or Superficial Chest Blocks N/A
Recruiting NCT03480308 - Effect of Addition of Fentanyl or Dexamethasone or Both to Bupivacaine in Paravertebral Block for Patients Undergoing Major Breast Surgery N/A